AI Article Synopsis

  • The study examined how abstinence-contingent wage supplements help unemployed adults in opioid agonist treatment improve drug abstinence and employment compared to usual care methods.
  • Participants in the wage supplement group showed better outcomes during the intervention phase, providing more negative urine samples for drugs and achieving higher employment rates.
  • However, after the intervention ended, both groups exhibited similar rates of drug use and employment, suggesting that the benefits of wage supplements may not be long-lasting once the financial incentives are removed.

Article Abstract

Background: Substance use disorder, unemployment, and poverty are interrelated problems that have not been addressed adequately by existing interventions. This study evaluated post-intervention effects of abstinence-contingent wage supplements on drug abstinence and employment.

Methods: Unemployed adults enrolled in opioid agonist treatment were randomly assigned to an abstinence-contingent wage supplement group (n = 44) or a usual care control group (n = 47). All participants could work with an employment specialist throughout a 12-month intervention period. Those in the abstinence-contingent wage supplement group earned stipends for working with the employment specialist and, after gaining employment, abstinence-contingent wage supplements for working in their community job but had to provide opiate- and cocaine-negative urine samples to maximize pay. To assess post-intervention effects of abstinence-contingent wage supplements and compare those effects to during-intervention effects, we analyzed urine samples and self-reports every 3 months during the 12-month intervention and the 12-month post-intervention period.

Results: During the intervention, abstinence-contingent wage supplement participants provided significantly more opiate- and cocaine-negative urine samples than usual care control participants; abstinence-contingent wage supplement participants were also significantly more likely to become employed and live out of poverty than usual care participants during intervention. During the post-intervention period, the abstinence-contingent wage supplement and usual care control groups had similar rates of drug abstinence, similar levels of employment, and similar proportions living out of poverty.

Conclusions: Long-term delivery of abstinence-contingent wage supplements can promote drug abstinence and employment, but many patients relapse to drug use and cease employment when wage supplements are discontinued.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885832PMC
http://dx.doi.org/10.1016/j.drugalcdep.2022.109322DOI Listing

Publication Analysis

Top Keywords

abstinence-contingent wage
40
wage supplements
24
wage supplement
20
drug abstinence
16
usual care
16
care control
12
urine samples
12
abstinence-contingent
10
wage
10
supplements promote
8

Similar Publications

Background: Alcohol use disorder, unemployment, and risk of homelessness are linked and often co-occurring, but most interventions do not address both alcohol use disorder and unemployment. The Abstinence-Contingent Wage Supplement (ACWS) model of the Therapeutic Workplace offers participants stipends or wage supplements contingent on both their abstaining from alcohol and engaging with an employment specialist or working in a community job. Wearable biosensors continuously tracked alcohol use.

View Article and Find Full Text PDF
Article Synopsis
  • A study looked at how giving people money for not drinking alcohol helped those who are homeless and struggle with alcohol problems.
  • They tested two groups: one got regular help and the other earned money for staying sober and working.
  • The group that tried to stay sober and got money was much better at not drinking, finding jobs, and improving their living situation compared to the group that only got regular help.
View Article and Find Full Text PDF
Article Synopsis
  • - The Abstinence-Contingent Wage Supplement (ACWS) trial combined workplace therapies with financial incentives for sobriety, successfully increasing participants' employment rates and abstinence from drugs.
  • - The study analyzed the costs of the ACWS intervention, finding it cost $11,310 per participant over a year, which is part of higher overall costs compared to usual care, totaling $30,686 for ACWS.
  • - Results suggest that ACWS is cost-effective, with incremental costs of $1,437 for negative drug tests and $915 for each additional employed participant, making it a viable option for addressing substance use disorders and unemployment when budgets allow.
View Article and Find Full Text PDF
Article Synopsis
  • The study examined how abstinence-contingent wage supplements help unemployed adults in opioid agonist treatment improve drug abstinence and employment compared to usual care methods.
  • Participants in the wage supplement group showed better outcomes during the intervention phase, providing more negative urine samples for drugs and achieving higher employment rates.
  • However, after the intervention ended, both groups exhibited similar rates of drug use and employment, suggesting that the benefits of wage supplements may not be long-lasting once the financial incentives are removed.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!